GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veeva Systems VEEV · USD

Health Care · US listing · 🇺🇸 United States

S&P 500

Compare

306.40

+0.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Veeva Systems

From its filings with the US Securities and Exchange Commission

SEC filings

Veeva Systems is based in Pleasanton, California and is incorporated in Delaware. Its shares trade on NYSE under the ticker VEEV. It is a member of the S&P 500. The SEC classifies its business as prepackaged software. In the fiscal year to 31 January 2026, it reported revenue of $3.20bn and net income of $908.9m. At that date it held total assets of $8.98bn and shareholders' equity of $7.21bn. By business, Subscription brought in 84.0% of revenue, followed by Professional services and other at 16.0%. By region, North America accounted for 59.6%, followed by Europe at 29.4% and Asia Pacific at 8.8%.

In its own words

Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions—from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our goal is to become the most strategic software, data, and business consulting partner to the life sciences industry, supporting the industry’s most critical drug development, quality and manufacturing, and commercialization functions.

Customer success is one of our core values, and our focus on it has allowed us to deepen and expand our strategic relationships with customers over time. Because of our industry focus, we have a unique, in-depth perspective into the needs and best practices of life sciences companies and clinical research sites. This allows us to develop targeted solutions, quickly adapt to regulatory changes, and incorporate highly relevant enhancements into our existing solutions at a rapid pace.

Quoted from its 10-K, filed 20 Mar 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
16 Oct 2013
Employees
7,928
Website
veeva.com ↗
Head office
4280 HACIENDA DRIVE, PLEASANTON, CA, 94588
Incorporated in
DE
Classification
Services-Prepackaged Software
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Gordon RitterIndependent Chairman of the Board$335,090
  • Mr. Thomas SchwengerPresident, Chief Customer Officer$5.2m
  • Ms. E. Nitsa ZuppasPresident, Chief of Staff$3.7m
  • Mr. Peter GassnerChief Executive Officer, Director, since 2007$172.4m
  • Mr. Brian Van WagenerChief Financial Officer$3.9m
  • Mr. Jonathan FaddisSenior Vice President, General Counsel, Secretary$3.2m
  • Mr. Timothy CabralIndependent Director, since 2010$275,034
  • Mr. Mark CargesIndependent Director$305,062
  • Dr. Mary HedleyIndependent Director$295,053
  • Ms. Priscilla HungIndependent Director$295,053
  • Mr. Marshall MohrIndependent Director$325,081
  • Mr. Paul SekhriIndependent Director$285,043

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
51
Environment
36
Social
63
Governance
53
Direct emissions (scope 1)
264 t
Energy emissions (scope 2)
280 t
Value chain emissions (scope 3)
49,237 t
Women in the workforce
44%
Carbon reduction policy
No
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.